Market Place
Sourcing Support
All News #Library
Biotech
OPKO Health`s Modex Therapeutics Begins MDX2301 Trial
08 Apr 2026 //
GLOBENEWSWIRE
OPKO Health to Participate in Jefferies Biotech on Beach Summit
27 Feb 2026 //
GLOBENEWSWIRE
OPKO, Entera Advance Oral Long-Acting PTH for Hypoparathyroidism
04 Feb 2026 //
GLOBENEWSWIRE
Regeneron Pledges $1B+ For Modex Multispecific Antibodies
29 Oct 2025 //
FIERCE BIOTECH
OPKO Health`s Modex Therapeutics Initiates MDX2004 Trial
28 Oct 2025 //
GLOBENEWSWIRE
OPKO & Entera Bio to Present Dual GLP-1 Tablet Data at ENDO 2025
25 Jun 2025 //
GLOBENEWSWIRE
OPKO Health to Join Piper Sandler Virtual Obesity Symposium
25 Jun 2025 //
GLOBENEWSWIRE
OPKO Health’s ModeX Therapeutics Forms Scientific Advisory Board
09 Jun 2025 //
GLOBENEWSWIRE
OPKO & Entera to Advance First Oral GLP-1/Glucagon Drug
19 Mar 2025 //
BIOSPACE
ModeX And Merck Begin Phase 1 Epstein-Barr Virus Vaccine Study
07 Jan 2025 //
GLOBENEWSWIRE
ModeX Secures $51 Million For COVID And Influenza Programs
07 Oct 2024 //
GLOBENEWSWIRE
Entera Bio And OPKO Health Update On Peptide Tablet Results
25 Sep 2024 //
GLOBENEWSWIRE
ModeX Secures BARDA Contract to Develop Novel Multispecific Antibodies
28 Sep 2023 //
GLOBENEWSWIRE
Merck, Opko Health sign deal for experimental Epstein-Barr virus vaccine
09 Mar 2023 //
REUTERS
ModeX Enters into Agreement with Merck to Develop Epstein-Barr Virus Vaccine
08 Mar 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.